HomeGreater Than Icon
Mutual FundsGreater Than Icon
Compare Mutual FundsGreater Than Icon
Edelweiss Mid Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

Edelweiss Mid Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

Edelweiss Mid Cap Fund - Direct (G)

9.2%

stock2

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

-

-

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

100

17748.32

2.04

127.753

January 1, 2013

0

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

19.71 %

23.52 %

9.2 %

14.01 %

19.35 %

7.4 %

Harshad Patwardhan

B.Tech(IIT), MBA(IIM) and CFA. B.Tech (IIT), MBA (IIM) and CFA.

Mr. Patwardhan has an overall work experience of over 23 years in the investment management function and has joined Edelweiss AMC as Chief Investment Officer - Equity and a key personnel. Prior to joining Edelweiss AMC, he was associated with JPMorgan Asset Management India Private Limited since June 2006 as CIO-Equies. Prior to that Mr. Patwardhan worked for two years with Deutsche Equies India Private Limited as a senior research analyst and has had extensive experience with several foreign brokerage houses covering a variety of sectors.

Trideep Bhattacharya

CFA, B.Tech form IIT, Kharagpur and MBA (Finance)

Mr. Trideep Bhattacharya has over 14 years' experience as a Portfolio Manager and Research Analyst. Prior to joining Edelweiss, he has worked as Senior Portfolio Manager - Alternate Equities with Axis Asset Management Company Limited, Head of Research with Motilal Oswal Securities Limited and Portfolio Manager with State Street Global Advisors and UBS Global Asset Management Limited.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right